FDA Adverse Event Injury Summary report: N

CODMAN HAKIM PROGRAMMABLE VALVE

MDR report key: 8152412 · Received December 11, 2018

Report

Report Number
1226348-2018-10861
Event Type
Injury
Date Received
December 11, 2018
Date of Event
November 20, 2018
Report Date
November 22, 2018
Manufacturer
CODMAN & SHURTLEFF, INC.
Product Code
JXG
PMA / PMN Number
K974739
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

IT WAS INITIALLY REPORTED THAT THE DEVICE WOULD BE RETURNED FOR EVALUATION. HOWEVER, MULTIPLE ATTEMPTS TO OBTAIN THE SAMPLE WERE UNSUCCESSFUL. THIS REPORT HAS BEEN UPDATED TO REFLECT THE CORRECTED INFORMATION. COMPLAINT SAMPLE WAS NOT RETURNED TO CODMAN AND NO PRODUCT OR LOT NUMBER INFORMATION HAS BEEN PROVIDED; THEREFORE, AN EVALUATION OF THE DEVICE COULD NOT BE PERFORMED AND MANUFACTURING RECORDS COULD NOT BE REVIEWED. THE CAUSE(S) OF THE DIFFICULTY REPORTED BY THE CUSTOMER COULD NOT BE DETERMINED. IF THE COMPLAINT SAMPLE BECOMES AVAILABLE, THIS COMPLAINT WILL BE REOPENED, AND THE RESPECTIVE EVALUATION PERFORMED. TRENDS WILL BE MONITORED FOR THIS OR SIMILAR COMPLAINTS. AT PRESENT, WE CONSIDER THIS COMPLAINT TO BE CLOSED.

Additional Manufacturer Narrative · 1

UDI -- UNKNOWN PART NUMBER, ATTEMPTS TO OBTAIN PRODUCT WERE UNSUCCESSFUL, UDI UNAVAILABLE. TWO POTENTIAL PRODUCT CODES WERE REPORTED: 823160, 823832; HOWEVER, NEITHER COULD BE CONFIRMED BY THE REPORTER. IT HAS BEEN REPORTED THAT THE DEVICE WILL BE RETURNED FOR EVALUATION. UPON COMPLETION OF THE INVESTIGATION, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

AS REPORTED BY THE AFFILIATE, THE VALVE APPEARED TO BE HEAVILY CALCIFIED WITH A WHITE MATERIAL. THE PATIENT HAS A HISTORY OF SHUNT REVISIONS. THE VALVE WILL BE RETURNED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
993199 CODMAN HAKIM PROGRAMMABLE VALVE SHUNT, CENTRAL NERVOUS SYSTEM & COMPS JXG CODMAN & SHURTLEFF, INC. NI

Patients

Seq Age Sex Outcome Treatment
1 70 YR Other